WHO Prequalifies Multi-Dose RSV Vaccine Vial to Enhance Global Infant Protection
The World Health Organization (WHO) has prequalified a multi-dose RSV (Respiratory Syncytial Virus) vaccine vial. This development is expected to facilitate broader access and protection for more infants globally against RSV, a common cause of respiratory illness.
Want more?
Open NewsSnap.ai for the full app experience, including audio, personalization, and more news tools.